Merit Medical Systems Files 8-K Report

TL;DR

MMSI filed an 8-K, mostly procedural stuff, no major news.

AI Summary

On November 1, 2024, Merit Medical Systems, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements and exhibits. No specific financial figures or material events beyond the filing itself were detailed in the provided text.

Why It Matters

This filing indicates Merit Medical Systems, Inc. is providing updates or submitting required financial documentation to the SEC, which is standard corporate disclosure.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report without disclosure of significant negative events or financial distress.

Key Players & Entities

• MERIT MEDICAL SYSTEMS INC (company) — Registrant
• 0000856982-24-000100 (filing_id) — Accession Number
• November 1, 2024 (date) — Report Date
• 8012531600 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $210 million — tal cash consideration of approximately $210 million and the assumption of certain liabiliti

Filing Documents

• mmsi-20241101x8k.htm (8-K) — 53KB
• mmsi-20241101xex99d1.htm (EX-99.1) — 23KB
• mmsi-20241101x8k001.jpg (GRAPHIC) — 11KB
• mmsi-20241101xex99d1001.jpg (GRAPHIC) — 21KB
• 0000856982-24-000100.txt ( ) — 259KB
• mmsi-20241101.xsd (EX-101.SCH) — 3KB
• mmsi-20241101_lab.xml (EX-101.LAB) — 15KB
• mmsi-20241101_pre.xml (EX-101.PRE) — 9KB
• mmsi-20241101x8k_htm.xml (XML) — 5KB

01. Other Events

Item 8.01. Other Events. As previously reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on September 18, 2024, Merit Medical Systems, Inc., a Utah corporation ("Merit"), entered into an Asset Purchase Agreement (the "Purchase Agreement") with Cook Medical Holdings LLC, an Indiana limited liability company ("Cook Medical"), to purchase Cook Medical's lead management portfolio of medical devices and certain related assets for total cash consideration of approximately $210 million and the assumption of certain liabilities (collectively, the "Acquisition"). On November 1, 2024, Merit closed the transaction contemplated by the Purchase Agreement. The foregoing summary of the principal terms of the Purchase Agreement is not complete and is qualified in its entirety by the actual terms and conditions of the Purchase Agreement, a copy of which is included as an exhibit to the Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024 that Merit filed with the SEC on October 30, 2024. The representations, warranties, and other terms contained in the Purchase Agreement were made solely for the purposes of the Purchase Agreement and as of the dates set forth in the Purchase Agreement, were solely for the benefit of the parties to the Purchase Agreement, and may be subject to limitations agreed upon by the parties to the Purchase Agreement. Those representations and warranties may have been made for the purposes of allocating contractual risk between the parties to the Purchase Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors are not third-party beneficiaries under the Purchase Agreement and should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of Merit,

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits EXHIBIT NUMBER DESCRIPTION 99.1 Press Release, dated November 1, 2024, entitled " Merit Medical C ompletes Acquisition of Lead Management Portfolio from Cook Medical " 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MERIT MEDICAL SYSTEMS, INC. Date: November 1, 2024 By: /s/ Brian G. Lloyd Brian G. Lloyd Chief Legal Officer and Corporate Secretary 4

View Full Filing

View this 8-K filing on SEC EDGAR